EGFR and non-small cell lung carcinoma: Randomized controlled trials and meta‐analysis found adjuvant treatment with EGFR‐TKIs after surgery may improve the disease‐free survival (DFS) of patients with early‐stage NSCLC.17, 18, 19, 20